Search clinical trials for: GP681

Total 10 results

Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Recruiting

Study to Assess the Efficacy and Safety of GP681 Versus Placebo for Postexposure Prophylaxis Against Influenza

Influenza

China
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Recruiting

Study of GP681 Tablets Compared With Placebo in Patients With Influenza at High Risk of Influenza Complications

Influenza, Human

China
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Completed

A Clinical Study on the Safety and Efficacy of GP681 Tablets in the Treatment of Uncomplicated Acute Influenza

Influenza

China
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Completed

GP681 in Volunteers With Hepatic Impairment Compared With Healthy Volunteers

Healthy Volunteers | Hepatic Impairment

China
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Completed

Evaluation the Safety and Tolerance of GP681 Tablets in Healthy Subjects

Influenza

China
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Recruiting

Study to Assess Relative Bioavailability of GP681 Formulations in Healthy Chinese Male Subjects

Healthy Participants

China
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Completed

A Phase I Mass Balance Study of [14C]GP681 in Healthy Chinese Male Volunteers

Healthy Volunteers

China
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Completed

To Assess the Efficacy of GP681 Tablet Versus Placebo in Patients With Acute Uncomplicated Influenza Virus Infection

Influenza

China
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Recruiting

Study to Assess the Tolerability, Safety and Efficacy of GP681 Powder for Oral Suspension

Influenza

China
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Completed

A Study to Evaluate the Drug-drug Interactions (DDIs) of GP681 With Rosuvastatin, Digoxin, Itraconazole, Oseltamivir in Chinese Healthy Volunteers

Healthy Volunteers

China

3

Subscribe